US Bancorp’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-800
Closed -$824 4182
2023
Q3
$824 Hold
800
﹤0.01% 3799
2023
Q2
$1.54K Sell
800
-1,204
-60% -$2.07K ﹤0.01% 3744
2023
Q1
$1.62K Hold
2,004
﹤0.01% 3806
2022
Q4
$2.58K Hold
2,004
﹤0.01% 3712
2022
Q3
$3K Hold
2,004
﹤0.01% 3778
2022
Q2
$4K Hold
2,004
﹤0.01% 3688
2022
Q1
$8K Buy
2,004
+800
+66% +$2.68K ﹤0.01% 3482
2021
Q4
$3K Hold
1,204
﹤0.01% 3849
2021
Q3
$5K Hold
1,204
﹤0.01% 3673
2021
Q2
$8K Hold
1,204
﹤0.01% 3504
2021
Q1
$10K Hold
1,204
﹤0.01% 3304
2020
Q4
$10K Hold
1,204
﹤0.01% 3189
2020
Q3
$5K Buy
+1,204
New +$5.13K ﹤0.01% 3324

Other funds holding GMDA

US Bancorp's GMDA Position: Q4 2023 in Review

US Bancorp sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q4 2023, closing a stake of 800 shares — an estimated $824 sold.

US Bancorp first reported a position in GMDA in Q3 2020 and held it in 13 quarters. The position peaked at $10K in Q1 2021. 52 funds tracked by Wall St. Rank hold GMDA as of Q4 2023.

  • US Bancorp reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • US Bancorp sold 800 Gamida Cell Ltd. Ordinary Shares shares in Q4 2023, an estimated $824.
  • US Bancorp first reported a position in Gamida Cell Ltd. Ordinary Shares in Q3 2020 and held it in 13 quarters.
  • US Bancorp's Gamida Cell Ltd. Ordinary Shares position peaked at $10K in Q1 2021.
  • 52 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q4 2023.

Based on US Bancorp's 13F filing for Q4 2023, filed 9 Feb 2024.